As the only industry-focused conference that exclusively addressed challenges with cytokine-based drug development, we built and strengthened connections within the rapidly evolving space through cytokine assay solutions, preclinical modelling, protein prediction, and more.

We showcased specialized services to measure, analyze, and interpret cytokine activity in both preclinical and clinical settings, helping the leading cytokine-based drug developers better understand cytokine behaviors to navigate toxicity and efficacy challenges.

With industry leaders from OSE Immunotherapeutics, Sonnet Biotherapeutics, ModeX, Sanofi, Regeneron, Synthekine, Candel, and more showcasing their expertise and recent developments, this was the prime opportunity to profile services to the focused decision-makers of the community, with over half of the speakers being C-suite.

For those looking to align their brand within the cytokine sector and demonstrate their technical expertise, we partnered with them through bespoke commercial partnerships to help achieve their specific business needs.